Welcome to chemicalbook!
010-86108875
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook >> CAS DataBase List >> Vapreotide (trifluoroacetate salt)

Vapreotide (trifluoroacetate salt)

Vapreotide (trifluoroacetate salt) price.
4 prices
Selected condition:
Brand
  • Cayman Chemical
Package
  • 500μg
  • 1mg
  • ManufacturerCayman Chemical
  • Product number24558
  • Product descriptionVapreotide (trifluoroacetate salt) ≥95%
  • Packaging500μg
  • Price$95
  • Updated2026-04-30
  • Buy
  • ManufacturerCayman Chemical
  • Product number24558
  • Product descriptionVapreotide (trifluoroacetate salt) ≥95%
  • Packaging1mg
  • Price$149
  • Updated2026-04-30
  • Buy
  • ManufacturerCayman Chemical
  • Product number24558
  • Product descriptionVapreotide (trifluoroacetate salt) ≥95%
  • Packaging1mg
  • Price$135
  • Updated2024-03-01
  • Buy
  • ManufacturerCayman Chemical
  • Product number24558
  • Product descriptionVapreotide (trifluoroacetate salt) ≥95%
  • Packaging500μg
  • Price$86
  • Updated2024-03-01
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
Cayman Chemical 24558 Vapreotide (trifluoroacetate salt) ≥95% 500μg $95 2026-04-30 Buy
Cayman Chemical 24558 Vapreotide (trifluoroacetate salt) ≥95% 1mg $149 2026-04-30 Buy
Cayman Chemical 24558 Vapreotide (trifluoroacetate salt) ≥95% 1mg $135 2024-03-01 Buy
Cayman Chemical 24558 Vapreotide (trifluoroacetate salt) ≥95% 500μg $86 2024-03-01 Buy

Properties

solubility :Water: 1 mg/ml

Safety Information

Symbol(GHS):
Signal word:
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
Precautionary statements:

Description

Vapreotide is a peptide neurokinin-1 receptor (NK1) antagonist and analog of somatostatin (IC50 = 330 nM in a radioligand binding assay).1 It inhibits increases in vascular permeability stimulated by substance P (Item No. 24035) in a concentration-dependent manner in isolated guinea pig trachea and main bronchi. Vapreotide (8 nmol per animal) reduces substance P-induced biting and scratching in mice. It increases reaction time to heat stimuli in the hot plate and tail flick tests when administered at a dose of 512 μg/kg, indicating antinociceptive activity in mice.2 Vapreotide reduces plasma growth hormone (GH) increases induced by phenobarbital (Item Nos. 9001494 | 20987), morphine (Item No. ISO60147), and chlorpromazine (Item No. 16129), hypoglycemia-induced glucagon elevation, and glucose-induced insulin secretion in rats.3 It also decreases tumor weight and volume in a hamster model of pancreatic ductal adenocarcinoma and suppresses tumor growth and reduces GH secretion in SK-ES-1 and MNNG/HOS osteosarcoma mouse xenograft models.4,5WARNING This product is not for human or veterinary use.